Arvinas, Inc. ARVN
Set alert
7.52 USD -0.34 -4.33%
At close
7.60 +0.08 +1.06%
Pre-market · Nov 3, 7:00 AM ET
7.37 Day range 8.00
6.74 52-week range 14.51
- YTD
- -36.59%
- 1 year
- -25.84%
- Open
- 7.89
- Prev close
- 7.86
- Mkt cap
- 491.70M
- Vol
- 1.14M
- Avg vol
- 834.28K
- EPS
- 0.26
- P/E
- 28.92
- Div yield
- 0.00%
More statistics
- Low
- 7.37
- High
- 8.00
- Forward P/E
- -1.78
- Beta
- 1.96
- Short ratio
- 11.90
- Inst. own
- 110.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.20
- 200-d avg
- 24.08
- 1y target
- 58.55
MAX chart
Events in this range
- Feb 12, 2025Rating: Stifel · Buy → Buy
- Feb 12, 2025Rating: Guggenheim · Buy → Buy
- Feb 12, 2025Rating: BMO Capital · Outperform → Outperform
- Feb 12, 2025Rating: Oppenheimer · Outperform → Outperform
- Mar 7, 2025Rating: Citigroup · Neutral → Neutral
- Mar 11, 2025Rating: HC Wainwright & Co. · Buy → Buy
- May 1, 2025Earnings: 1.14; estimate —; surprise 232.56%
Signals (132)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 26, 2025 | 1 year ago |
| RSI: Oversold | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
Newest 20 of 132.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 58.55 +678.6% upside
Now 7.52
- Target (low)
- 19.00
- Target (mean)
- 58.55
- Target (high)
- 110.00
Ratings (0m) 22 19 buy · 3 hold · 0 sell
- Strong buy5
- Buy14
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
- 3 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.02 | -1.58 – -0.32 | -0.97 | -4.8% | 42.71M | +68.8% | 15 |
| Next quarter | -1.09 | -1.61 – -0.45 | -0.49 | -121.5% | 42.65M | -44.2% | 15 |
| Current year | -3.82 | -5.71 – -2.07 | -2.77 | -38.0% | 211.27M | -19.8% | 17 |
| Next year | -4.12 | -6.89 – 0.3234 | -3.82 | -7.9% | 236.17M | +11.8% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 7, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Feb 12, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 12, 2025 | BMO Capital | Reiterated | Outperform | Outperform |
| Feb 12, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Feb 12, 2025 | Stifel | Maintained | Buy | Buy |
| Feb 7, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Feb 3, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 12, 2024 | Guggenheim | Reiterated | Buy | Buy |
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Nov 18, 2024 | Stephens & Co. | Initiated | — | Overweight |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 31, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 31, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Jul 31, 2024 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| May 8, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| May 8, 2024 | Stifel | Maintained | Buy | Buy |
| May 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 15, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2024 | Truist Securities | Reiterated | Buy | Buy |
| Feb 29, 2024 | Barclays | Maintained | Overweight | Overweight |
| Feb 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |